布地奈德联合沙丁胺醇雾化吸入治疗新生儿肺炎的具体效果观察

目的：探讨布地奈德+沙丁胺醇雾化吸入对新生儿肺炎治疗效果。方法：选择我院2013年7月～2015年7月新生儿肺炎患者72例。通过抽签随机分组。B2组（对照组36例）：选择浓度为0.9%的氯化钠注射液实施雾化吸入；B1组（观察组36例）：选择布地奈德+沙丁胺醇实施雾化吸入。对比两组住院时间以及疾病症状改善程度。结果：临床治疗总有效率，B1组明显高于B2组（P<0.05）；在症状改善程度方面，B1组明显优于B2组（P<0.05）。结论：针对新生儿肺炎，临床选择沙丁胺醇+布地奈德雾化吸入进行治疗，表现出较高安全性，凸显临床价值。

Budesonide combined salbutamol aerosol inhalation observe specific effect for the treatment of neonatal pneumonia

Objective: to study the selection method of salbutamol aerosol inhalation budesonide + in patients with neonatal pneumonia after completion for the clinical effect of treatment. Methods: from July 2013~July 2015, 72 patients with neonatal pneumonia. Through the draw method for randomized patients with neonatal pneumonia. B2 group (the control group 36 cases): choose a concentration of 0.9% sodium chloride injection for patients with aerosol inhalation; B1 (observation group 36 cases): select budesonide + salbutamol aerosol inhalation for patients. Compared two groups of patients with neonatal pneumonia in terms of length of hospital stay and disease symptoms improved degree show the difference. Results: all the clinical total effective rate in patients with neonatal pneumonia , B1 group is significantly higher than B2 children (P<0.05); In terms of degree of symptoms improvement, B1 B2 is obviously better than the group patients (P<0.05). Conclusion: for patients with neonatal pneumonia, the clinical choice albuterol + budesonide aerosol inhalation method of treatment, show that the treatment of high security, highlighting the clinical value of treatment of patients with neonatal pneumonia.